Scarica l'app Stockscreener
37.66
4.90%
-1.94
Pre-mercato:
36.61
-1.05
-2.79%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$39.60
Aprire:
$40.58
Volume 24 ore:
609.02K
Relative Volume:
0.84
Capitalizzazione di mercato:
$1.39B
Reddito:
$154.15M
Utile/perdita netta:
$-33.58M
Rapporto P/E:
-39.23
EPS:
-0.96
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
-0.61%
1M Prestazione:
-10.61%
6M Prestazione:
+34.16%
1 anno Prestazione:
-11.26%
Intervallo 1D:
$36.95
$41.24
Intervallo di 1 settimana:
$36.77
$41.55
Portata 52W:
$20.85
$50.72
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
1A BURTON HILLS BLVD, NASHVILLE, CA
Confronta HROW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
37.66 | 1.47B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | BTIG Research | Buy |
| 2025-06-10 | Iniziato | William Blair | Outperform |
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
Why Harrow Inc. stock remains on watchlistsJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
Should I hold or sell Harrow Inc. stock in 2025Portfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
Harrow, Inc. Hits Day High with 7.65% Surge in Strong Intraday Performance - Markets Mojo
How Harrow Inc. stock performs in rising dollar environment2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
How Harrow Inc. stock reacts to job market dataJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
What insider trading reveals about Harrow Inc. stockBear Alert & Momentum Based Trading Signals - newser.com
Harrow, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HROW) 2025-11-19 - Seeking Alpha
How Harrow Inc. stock performs in rate cut cyclesEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Harrow officially acquires Melt Pharmaceuticals - Eyes On Eyecare
Detecting price anomalies in Harrow Inc. with AIJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Will Harrow's (HROW) Return to Profitability Reshape Its Growth Narrative? - simplywall.st
Analyzing Harrow Inc. with risk reward ratio charts2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Best data tools to analyze Harrow Inc. stockJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
Harrow Completes Its Acquisition of Melt Pharmaceuticals - VisionMonday.com
What analysts say about Harrow Inc stockStock Price Targets & Affordable Growth Investments - earlytimes.in
Will Harrow Inc. stock pay special dividendsMarket Trend Report & Weekly Top Stock Performers List - newser.com
Harrow completes acquisition of Melt Pharmaceuticals By Investing.com - Investing.com Nigeria
Harrow (HROW) Finalizes Acquisition of Melt Pharmaceuticals - GuruFocus
Harrow Health Completes Acquisition of Melt Pharmaceuticals - TipRanks
[8-K] HARROW, INC. Reports Material Event | HROW SEC FilingForm 8-K - Stock Titan
Harrow Closes Melt Pharmaceuticals Acquisition - MarketScreener
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals - The Manila Times
Harrow (Nasdaq: HROW) Closes Melt Deal, Sets MELT-300 NDA Filing for 2027 in U.S. - Stock Titan
What risks investors should watch in Harrow Inc. stockTrend Reversal & Accurate Entry/Exit Alerts - newser.com
Should you hold or exit Harrow Inc. now2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
Why Harrow Inc. stock is in analyst buy zone2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
Key resistance and support levels for Harrow Inc.July 2025 Momentum & Low Risk Investment Opportunities - newser.com
Harrow Inc. stock volume spike explainedJuly 2025 News Drivers & Reliable Volume Spike Alerts - newser.com
Custom watchlist performance reports with Harrow Inc.July 2025 Recap & Low Risk Growth Stock Ideas - newser.com
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.17%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):